Bio-Path Holdings
  • About Bio-Path
    • Overview
    • Leadership
    • Scientifc Advisory Board
    • Directors
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us

Form 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities


Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities 

Form 8-K: Item 5.02 Departure of Directors or Certain Officers

BPTH_20250624_8-K

SEC Form 1-A/A

BPTH_1-A-A_20250516

SEC Form 10-Q: For Period ending March 31, 2025

BPTH_20250515_10-Q

SEC Form 8-K: Press Release dated May 1, 2025

BPTH_8-K_20250502

SEC Form 8-K: Entry into a Material Definitive Agreement

BPTH_8-K_20250429

SEC Form 1-A

BPTH_Form_1-A_20250411

SEC: Withdrawal of Registration Statement on Form S-1

BPTH_25-3664-12__RW_20250409

SEC Form 8-K: Entry into a Material Definitive Agreement

BPTH_8-K_25-10724

SEC Form 8-K: Press Release dated March 28, 2025

BPTH20250327_8-K

Bio-Path Holdings

All Rights Reserved

Office:

625 Stanwix Street
Pittsburgh, PA, 15222

T: (630) 708-0750

logo
  • About Bio-Path
    • Overview
    • Leadership
    • Scientifc Advisory Board
    • Directors
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us